You Position: Home > Paper
2020年高血压领域研究热点盘点
( views:137, downloads:115 )
- Author:
- No author available
- Journal Title:
- Prevention and Treatment of Cardio-Cerebral-Vascular Disease
- Issue:
- 1
- DOI:
- 10.3969/j.issn.1009-816x.2021.01.004
- Key Word:
- No keyword available
Abstract： 高血压对于全球健康的威胁依旧存在,涉及不同年龄、不同种族、不同性别的诸多人群.2020 年突如其来的新型冠状病毒肺炎(corona virus disease 2019,COVID-19)又使得高血压的防治迎来了新的挑战.过去的一年,国际社会在高血压的基础、人群防治方面开展了很多研究,也包括了与COVID-19 相关的高血压诊治方面的研究.采撷其精华,对于我们进一步提高高血压的管理必有裨益.
- [1]Nambiar, Lakshmi,LeWinter, Martin M.,VanBuren, Peter C.,etc.Decade-Long Temporal Trends in US Hypertension-Related Cardiovascular Mortality[J].2020,75(20).
- [2]Jafar, Tazeen H.,Gandhi, Mihir,De Silva, H. Asita,etc.A Community-Based Intervention for Managing Hypertension in Rural South Asia[J].2020,382(8).
- [3].Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19[J].2020,382(25).
- [4].Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older The OPTIMISE Randomized Clinical Trial[J].2020,323(20).
- [5].Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment A Systematic Review and Meta-analysis[J].2020,323(19).
- [6].Sex Differences in Blood Pressure Trajectories Over the Life Course[J].2020,5(3).
- [7].Effect of a Workplace-Based Multicomponent Intervention on Hypertension Control A Randomized Clinical Trial[J].2020,5(5).
- [8].Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19[J].2020,382(25).